Are Aerospace Stocks Lagging Axon Enterprise (AXON) This Year?
ZACKS· 2025-02-03 23:40
For those looking to find strong Aerospace stocks, it is prudent to search for companies in the group that are outperforming their peers. Axon Enterprise (AXON) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Aerospace peers, we might be able to answer that question.Axon Enterprise is a member of our Aerospace group, which includes 51 differe ...
Tufts University School of Medicine, ATI Physical Therapy launch first-of-its-kind collaboration to make physical therapy education and career advancement more accessible and affordable
Prnewswire· 2025-02-03 23:40
New collaboration responds to growing demand for highly trained physical therapistsCHICAGO, Feb. 3, 2025 /PRNewswire/ -- With demand for physical therapy services projected to increase 27 percent by 2030, Tufts University School of Medicine (TUSM) and ATI Physical Therapy (ATI), a leading provider of physical therapy services across the United States, are launching a joint initiative aimed at expanding the physical therapist workforce and making the Doctor of Physical Therapy (DPT) Programs at TUSM more acc ...
Constellation Stock Hits 4-Year Low on Mexico Tariffs
Schaeffers Investment Research· 2025-02-03 23:38
Constellation Brands Inc (NYSE:STZ) stock is down 1.9% to trade at $177.47 at last glance, after President Donald Trump imposed a 25% tariff on goods from Mexico. The company's Mexican imports include Modelo and Corona beers, the former of which became America's top seller after beating Anheuser-Busch Inbev's (BUD) Bud Light in 2023. Piper Sandler was quick to downgrade STZ on potential tariff headwinds, lowering its rating to "neutral" from "overweight," with a price-target cut to $200 from $245.Constellat ...
Biogen Stock Down on Regulatory Update in the EU for Alzheimer's Drug
ZACKS· 2025-02-03 23:35
Biogen (BIIB) and Japan-based partner, Eisai, announced an update regarding the regulatory review of an application seeking the approval of Leqembi (lecanemab) for mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD, collectively known as early AD, in the EU.Please note that, in November 2024, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) rendered a positive opinion recommending marketing approval for Leqembi for early AD.Biogen and Eisai annou ...
Best Value Stocks to Buy for February 3rd
ZACKS· 2025-02-03 23:35
Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 3rd: NextEra Energy Partners (NEP) : This company which acquire, manage and own contracted clean energy projects with stable long-term cash flows, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 37.8% over the last 60 days.NextEra Energy has a price-to-earnings ratio (P/E) of 6.9 compared with 30.2 for the industry. The com ...
After Plunging -5.28% in 4 Weeks, Here's Why the Trend Might Reverse for California Resources (CRC)
ZACKS· 2025-02-03 23:35
California Resources Corporation (CRC) has been on a downward spiral lately with significant selling pressure. After declining 5.3% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotti ...
SurModics (SRDX) Loses -13.87% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-02-03 23:35
A downtrend has been apparent in SurModics (SRDX) lately with too much selling pressure. The stock has declined 13.9% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for s ...
YmAbs Therapeutics (YMAB) Loses -26.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-02-03 23:35
Y-mAbs Therapeutics, Inc. (YMAB) has been on a downward spiral lately with significant selling pressure. After declining 26.9% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting wh ...
Zentalis Pharmaceuticals (ZNTL) Loses -46.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-02-03 23:35
Zentalis Pharmaceuticals, Inc. (ZNTL) has been beaten down lately with too much selling pressure. While the stock has lost 46.3% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentu ...
After Plunging -14.42% in 4 Weeks, Here's Why the Trend Might Reverse for Deckers (DECK)
ZACKS· 2025-02-03 23:35
文章核心观点 - 德克斯户外用品公司(DECK)近期股价呈下降趋势,但因处于超卖区域且华尔街分析师看好其盈利,股价可能反弹 [1] 超卖股票识别指南 - 相对强弱指数(RSI)是常用技术指标,用于判断股票是否超卖,它是衡量价格变动速度和变化的动量振荡器 [2] - RSI在0到100之间波动,通常RSI读数低于30时,股票被视为超卖 [2] - RSI能帮助快速轻松检查股票价格是否接近反转点,若因不合理抛售压力使股价远低于公允价值,投资者可寻找入场机会 [3] - RSI有局限性,不应单独用于投资决策 [4] 德克斯户外用品公司股价反弹原因 - 该公司股票RSI读数为27.7,表明大量抛售可能已接近尾声,股价趋势可能很快反转以恢复供需平衡 [5] - 卖方分析师对该公司本年度盈利预测上调达成强烈共识,过去30天内每股收益(EPS)共识预测提高7.8%,盈利预测上调通常会在短期内推动股价上涨 [6] - 该公司目前Zacks排名为2(买入),意味着在基于盈利预测修正趋势和每股收益意外表现排名的4000多只股票中处于前20%,这更有力地表明其股价短期内可能反转 [7]